Skip to main content
Fig. 3 | Journal of Neuroinflammation

Fig. 3

From: Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer’s disease

Fig. 3

MDP treatment had no effect on microglial activation, and APP levels, but upregulated COX2 levels in APP mice. a Immunoblot analysis of APP levels in the cortex and hippocampus of APP mice treated with vehicle and MDP. b, c Immunoblot analysis of Iba1 and TREM2 levels in the cortex and hippocampus of APP mice treated with vehicle and MDP. d Immunoblot analysis of COX2 levels in the cortex and hippocampus of APP mice treated with vehicle and MDP. Data are expressed as the means ± SEM; ***P < 0.0001 vs. APP-MDP

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094